HBOT News & Research
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Oxygen Under Pressure Resolving TBI’s & Suicide – Hailed as Most Important Scientific Breakthrough for 2019
Research Triangle Park, NC (January 21, 2020) - Congressman Andy Biggs (AZ-05) and Senator Kevin Cramer (R-ND) recently introduced the TBI and PTSD Treatment Act [House Bill 4370; Senate Bill 2504], in late 2019 to direct the Veterans...
When to worry about sudden hearing loss and what to do about it
Sudden sensorineural hearing loss (SSNHL), also known as sudden deafness, is hearing loss that is not caused by trauma - like a firecracker exploding next to your ear. It is an unexplained and rapid hearing loss that can happen overnight. SSNHL...
The effect of hyperbaric oxygenation therapy on myocardial function
Abstract: Hyperbaric oxygenation therapy is successfully implemented for the treatment of several disorders. Data on the effect of hyperbaric oxygenation on echocardiographic parameters in asymptomatic patients is limited. The current study sought...
Investigational HBOT indications: Inflammatory bowel disease
One of the earliest documented cases of HBOT to treat complications of Crohn’s disease (CD) was in 1989. It was a woman with "severe perineal CD that defied medical therapy for eight years". In this particular case the woman was treated with...
Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status
Abstract Low circulating pyridoxal 5'-phosphate (PLP) concentrations have been linked to inflammatory markers and the occurrence of inflammatory diseases. However, the implications of these findings are unclear. The measurement of PLP and...
Beta Neurofeedback Training Improves Attentional Control in the Elderly
Abstract One of the well-documented behavioral changes that occur with advancing age is a decline in executive functioning, for example, attentional control. Age-related executive deficits are said to be associated with a deterioration of the...
Hyperbaric oxygen therapy in the prevention and management of tracheal and oesophageal anastomotic complications
Abstract: OBJECTIVES: Failure of anastomotic healing is a morbid complication after airway or oesophageal surgery. Hyperbaric oxygen therapy (HBOT) has been used extensively in the management of complex wound-healing problems. We demonstrate the...
Glutathione as a mediator of cartilage oxidative stress resistance and resilience during aging and osteoarthritis
Abstract Purpose: An underlying cause of osteoarthritis (OA) is the inability of chondrocytes to maintain homeostasis in response to changing stress conditions. The purpose of this article was to review and experimentally evaluate oxidative stress...
Local doctor continues to push VA to approve Hyperbaric Oxygen Therapy for veterans
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.